Skip to main content
OpenTrials
Completed

NCT Number: NCT02162095

Is COPD a Risk Factor for Cardiovascular Disease?

Patients with chronic obstructive pulmonary disease suffer from significant cardiovascular morbidity and mortality. This study wants to determine whether chronic obstructive pulmonary disease might be a risk factor for coronary atherosclerosis and other cardiac markers independent of conventional cardiovascular risk factors. The study is designed as a retrospective matched case-control study with follow-up via telephone interview.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Patients with chronic obstructive pulmonary disease (COPD) suffer from significant cardiovascular morbidity and mortality. Coronary artery disease has often been linked causally to COPD, but the exact pathophysiological mechanisms underpinning this association remain speculative. A retrospective case-control study matching COPD patients and controls one to one for smoking history and conventional cardiovascular risk factors will be performed to study the association between COPD and cardiovascular outcomes. Filling in this knowledge gap may contribute to the understanding of the interplay between COPD and cardiovascular disease.

The objective of this retrospective case-control study is to determine whether COPD might be a risk factor for coronary atherosclerosis, impaired left ventricular ejection fraction, and major adverse cardiovascular events independent of conventional cardiovascular risk factors.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • SPECT-CT imaging due to preoperative assessment between 01.01.2007 and 31.07.2013.
  • Coronary artery calcium score and left ventricular ejection fraction data available.
  • History of smoking (smoker or ex-smoker).
  • COPD group: Documented chronic obstructive pulmonary disease (post-bronchodilator FEV1/FVC < 0.7).
  • Control group: Exclusion of chronic obstructive pulmonary disease (post-bronchodilator FEV1/FVC > 0.7).

Exclusion criteria

  • Known coronary artery disease or coronary symptoms (angina pectoris) at the time of the SPECT-CT investigation.
  • Known congenital or structural heart disease.
  • Previous heart transplantation.

Treatment and study plan

Primary outcomes

  1. Coronary calcium score in cardiac computed tomography

    Time frame: Up to one month

    Retrospective assessment of SPECT-CT imaging data at the University Hospital Zurich.

Secondary outcomes

  1. Left ventricular ejection fraction in single-photon emission computed tomography

    Time frame: Up to one month

    Retrospective assessment of SPECT-CT imaging data at the University Hospital Zurich.

  2. Major adverse cardiovascular events

    Time frame: Up to three months

    Follow-up via telephone interview for major adverse cardiovascular events.

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Collaborators

  • University Hospital, Zürich

Registry information

Official study title

Is Chronic Obstructive Pulmonary Disease a Risk Factor for Cardiovascular Disease?

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Jun 12, 2014
Registry last updated
Jun 3, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.